TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.
PHASE3
Optimization of second-line therapy with aflibercept, irinotecan (day1 or d...
A Non-Interventional Follow-Up to the VELOUR Study - Translational Research
N/A
This is a follow-on study to the VELOUR trial (NCT00561470). The aim of thi...
Status
Unknown
Location
Thomas Jefferson University Hospital
Start Date
2012-01
Trial ID
NCT01754272
Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
PHASE3
The main objective of the study was to evaluate the effectiveness of aflibe...
Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen
PHASE2
The purpose of this study is to assess the efficacy and safety of treatment...
Status
Completed
Location
Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms
PHASE2
The purpose of this study is to assess FOLFIRI+aflibercept efficacy in pati...
Status
Completed
Location
Spanish Cooperative Group for the Treatment of Digestive Tumors